These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1665989)

  • 1. Serum peptide III-procollagen and ACE in asbestos workers.
    Owczarek H; Lewczuk E
    Pol J Occup Med Environ Health; 1991; 4(2):127-33. PubMed ID: 1665989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Procollagen III-peptide and angiotensin converting enzyme in bronchoalveolar lavage in sarcoidosis].
    Schlotfeldt D; Nowak B; Weist P
    Pneumologie; 1992 Mar; 46(3):101-6. PubMed ID: 1316603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum type III procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis.
    Cavalleri A; Gobba F; Bacchella L; Luberto F; Ziccardi A
    Br J Ind Med; 1988 Dec; 45(12):818-23. PubMed ID: 3219307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of blood procollagen III peptide as an early indicator of pulmonary fibrosis in exposure to asbestos].
    Cavalleri A; Gobba FM; Ferrari D; Bacchella L; Candela S; Magnani N
    Med Lav; 1988; 79(5):351-62. PubMed ID: 3252126
    [No Abstract]   [Full Text] [Related]  

  • 5. Health effects of asbestos exposure in humans: a quantitative assessment.
    Boffetta P
    Med Lav; 1998; 89(6):471-80. PubMed ID: 10217936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Asbestos fibre lung burden and exposure indices in asbestos-cement workers].
    Barbieri PG; Somigliana A; Lombardi S; Girelli R; Benvenuti A
    Med Lav; 2009; 100(1):21-8. PubMed ID: 19263869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary regarding the article by Fischer et al.: Fibre years, pulmonary asbestos burden and asbestosis. Int. J. Hyg. Environ. Health 205, 245-248 (2002).
    Rödelsperger K; Woitowitz HJ
    Int J Hyg Environ Health; 2003 Jun; 206(3):245-7; author reply 251-2. PubMed ID: 12872536
    [No Abstract]   [Full Text] [Related]  

  • 8. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary regarding the article by Fischer et al.: Fibre years, pulmonary asbestos burden and asbestosis. Int. J. Hyg. Environ. Health 205, 245-248 (2002).
    Henderson DW
    Int J Hyg Environ Health; 2003 Jun; 206(3):249-50; author reply 251-2. PubMed ID: 12872537
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
    van Dijk DJ; Boner G; Giler S; Erman A
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Markers of fibrogenesis in bronchoalveolar lavage and in serum of workers exposed to asbestos].
    Salberini I; Rivolta G; Todaro A; Forni A; Annoni G; Chiappino G
    Med Lav; 1991; 82(3):238-47. PubMed ID: 1795668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum procollagen III peptide levels in subjects with sarcoidosis. A 5-year follow-up study.
    Pohl WR; Thompson AB; Köhn H; Losch S; Umek H; Legenstein E; Kummer F; Rennard SI; Klech H
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):412-7. PubMed ID: 1310576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte-derived growth factors in asbestos-induced interstitial fibrosis.
    Schwartz DA; Rosenstock L; Clark JG
    Environ Res; 1989 Aug; 49(2):283-94. PubMed ID: 2473896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic alterations of angiotensin-II and nitric oxide in radiation pulmonary fibrosis.
    Song L; Wang D; Cui X; Shi Z; Yang H
    J Environ Pathol Toxicol Oncol; 1998; 17(2):141-50. PubMed ID: 9546751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procollagen III peptide in bronchoalveolar lavage fluid. A potential marker of altered collagen synthesis reflecting pulmonary disease in sarcoidosis.
    Bjermer L; Thunell M; Hällgren R
    Lab Invest; 1986 Dec; 55(6):654-6. PubMed ID: 3023750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on the inhibition effect of tetrandrine on the pingyangmycinum induced pulmonary fibrosis].
    Jin H
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Dec; 14(6):359-61, 378. PubMed ID: 1726367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective action of taurine and L-arginine in radiation pulmonary fibrosis.
    Song L; Wang D; Cui X; Hu W
    J Environ Pathol Toxicol Oncol; 1998; 17(2):151-7. PubMed ID: 9546752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme as a possible marker for lung toxicity in amiodarone-treated patients.
    Foresti V; Pepe R; Parisio E; De Filippi G; Scolari N; Frigerio C
    Int J Clin Pharmacol Res; 1989; 9(4):261-7. PubMed ID: 2550378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidence of asbestosis in Poland].
    Wilczyńska U; Szeszenia-Dabrowska N
    Med Pr; 2002; 53(5):375-9. PubMed ID: 12577804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum aminoterminal propeptide of type III procollagen as an early marker of the active fibrotic process in asbestos-exposed workers.
    Cavalleri A; Gobba F; Bacchella L; Ferrari D
    Scand J Work Environ Health; 1991 Apr; 17(2):139-44. PubMed ID: 2047816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.